Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Business Wire

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
CELH Deadline: Rosen Law Firm Urges Celsius Holdings, Inc. (NASDAQ: CELH) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers CELH
News headline image
Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 Study Conducted by Akeso in China
From Summit Therapeutics
Via Business Wire
Tickers SMMT
News headline image
Sonesitatug vedotin reduced the risk of death by 42% in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers in CLARITY-Gastric01
From AstraZeneca
Via Business Wire
Tickers AZN
News headline image
TAGRISSO® (osimertinib) plus savolitinib reduced the risk of disease progression or death by 45% and the risk of death by 32% in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO
From AstraZeneca
Via Business Wire
Tickers AZN
News headline image
Genentech’s Divarasib Demonstrated Best-in-Class Efficacy, Advancing the Standard of Care in Previously Treated KRAS G12C-mutated Lung Cancer
From Genentech
Via Business Wire
Tickers RHHBY
News headline image
HIMS Deadline: Rosen Law Firm Urges Hims & Hers Health, Inc. (NYSE: HIMS) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers HIMS
News headline image
Genmab Announces Updated Follow-Up Analyses from Phase 2 Study of Petosemtamab Demonstrate Meaningful Objective Response Rates in Patients with Metastatic Colorectal Cancer
From Genmab A/S
Via Business Wire
Tickers GMAB
News headline image
Agenus Reports 72% of Patients with Locally Advanced dMMR Colon Cancer Had No Cancer Remaining at Surgery Following Six Weeks of BOT+BAL in Phase 2 NEOASIS Study at ESMO 2026
From Agenus Inc.
Via Business Wire
Tickers AGEN
News headline image
Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell Renal Cell Carcinoma and ENPP3+ Tumors
From Xencor, Inc.
Via Business Wire
Tickers XNCR
News headline image
Frontier Medicines Presents Promising Anti-Tumor Activity from Phase 1/2 PROSPER Trial of FMC-376 in a Highly Resistant Patient Population of KRAS G12C-Mutant NSCLC at ESMO 2026
From Frontier Medicines
Via Business Wire
News headline image
CCC Investors Have Opportunity to Join CCC Intelligent Solutions Holdings Inc. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
Tickers CCC
News headline image
PZZA Deadline: Rosen Law Firm Urges Papa John’s International, Inc. (NASDAQ: PZZA) Stockholders to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers PZZA
News headline image
Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
SSTI Stock Alert: Halper Sadeh LLC is Investigating Whether SoundThinking, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
Tickers SSTI
News headline image
IMFINZI® (durvalumab) plus tarlatamab-dlle reduced the risk of death by 58% in 1st-line extensive-stage small cell lung cancer in the DeLLphi-305 Phase III trial
From AstraZeneca
Via Business Wire
Tickers AZN
News headline image
Perioperative IMFINZI® (durvalumab) plus neoadjuvant enfortumab vedotin reduced risk of recurrence by 49% and risk of death by 42% in muscle-invasive bladder cancer
From AstraZeneca
Via Business Wire
Tickers AZN
News headline image
HHS Stock Alert: Halper Sadeh LLC is Investigating Whether Harte Hanks, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
Tickers HHS
News headline image
GPRO Stock Alert: Halper Sadeh LLC is Investigating Whether GoPro, Inc. is Obtaining a Fair Price for its Shareholders
From Halper Sadeh LLC
Via Business Wire
Tickers GPRO
News headline image
ESMO 2026: NUBEQA® (darolutamide) Plus ADT and Radiation Therapy Reduces Risk of Metastasis or Death by 58% in Prostate Cancer Patients at High Risk of Recurrence
From Bayer
Via Business Wire
Tickers BAYRY BAYZF
News headline image
Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026
From Semtech Corporation
Via Business Wire
Tickers SMTC
News headline image
Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
From Genmab A/S
Via Business Wire
Tickers GMAB INCY
News headline image
Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer
From Incyte
Via Business Wire
Tickers INCY
News headline image
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026
From BeOne Medicines Ltd.
Via Business Wire
Tickers ONC
News headline image
CatalYm Presents Phase 2 Data Showing Visugromab Substantially Enhances the Clinical Benefit of PD-1 Inhibition in Neoadjuvant Bladder Cancer at ESMO 2026
From CatalYm
Via Business Wire
News headline image
Slate Grocery REIT Announces Receipt of Interim Order, and Provides Meeting and Circular Details
From Special Committee of Slate Grocery REIT
Via Business Wire
News headline image
Genesis Healthcare Announces Effective Date of Chapter 11 Plan Following Consummation of Sale to West State Street
From Genesis Healthcare, Inc.
Via Business Wire
News headline image
Rosen Law Firm Encourages NVE Corporation Investors to Inquire About Securities Class Action Investigation - NVEC
From The Rosen Law Firm, P.A.
Via Business Wire
Tickers NVEC
News headline image
US Metro Bancorp Announces Third Quarter 2026 Results
From US Metro Bancorp
Via Business Wire
Tickers USMT
News headline image
Travere Presents New Biomarker Data at ASN Kidney Week Suggesting FILSPARI® (sparsentan) May Modify Underlying Disease Pathophysiology in IgA Nephropathy
From Travere Therapeutics, Inc.
Via Business Wire
Tickers TVTX
News headline image
Hawaiian Electric Industries to Announce Third Quarter 2026 Results November 6
From Hawaiian Electric Industries, Inc.
Via Business Wire
Tickers HE
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.